Board of Directors

Doug McNair, MD, Ph.D., President, Cerner Math

Doug is the President of Cerner Math, a subsidiary of Cerner Corporation.  Cerner Math develops specialized analytics used to discern patterns in raw data and build predictive, actionable models from the data. Prior to this, he was a Senior Vice President at Cerner, focused on the company’s research and development efforts. He joined Cerner in 1986, first as general manager for Cerner’s Detroit and Kansas City branches; then as vice president of regulatory affairs, responsible for both submissions and compliance.  He is co-inventor and co-developer of Cerner’s clinical decision support system, Discern Expert®.

Doug came to Cerner from Select Therapeutics, Inc., where he was senior vice president for research and development. There, he was responsible for the company’s clinical development programs and regulatory affairs activities. He also invented two patent applications on cell therapy-related hybrid drug delivery medical devices. Before that, he was vice president for clinical development at Abiomed, where he authored investigational plans and protocols for all products and was responsible for clinical trials, both in North America and in Europe. He was also a faculty member of Baylor College of Medicine, in the Departments of Medicine and Pathology, and co-directed the Biostatistics and Design & Analysis Unit under Drs. Tony Gotto and Michael Debakey.  Doug has a Ph.D. is biomedical engineering and an MD, both from the University of Minnesota.

Wendy Threader, Professor, Algonquin College

An early investor in Therapeutic Monitoring Systems, Wendy has over twenty five years’ experience in both the private and public high technology sectors.  Wendy was the founder and President of AMC Inc., a Canadian service provider business in the telecommunications field that was successfully sold in 1998 to an American telecommunications company.  During this tenure Wendy was selected in the Ottawa, Ontario business community as a “Top 40 under 40” entrepreneur.

Before founding AMC Inc. she held a variety of roles with increasing responsibility for Nortel Networks.  Currently she is Coordinator of the Business Administration program and full time Professor of Marketing and Management studies at Algonquin College in Ottawa, Ontario.   She is also the founder and President of AMC Consulting, offering consulting services in finance, accounting, business planning and marketing planning.  Past board positions include The Canadian Diabetes Association, The Juvenile Diabetes Association, Barrhaven Childcare (President) and the Children’s Hospital of Eastern Ontario Volunteer Board.

Dr. Andrew J. Seely, Founder & Chief Science Officer

Andrew is an Associate Professor of Surgery within the Divisions of Thoracic Surgery and Critical Care Medicine at the University of Ottawa, Scientist with the Ottawa Hospital Research Institute, Chair of Research for the Canadian Association of Thoracic Surgeons, and Director of Research for the Ottawa Department of Surgery and the Division of Thoracic Surgery.  Education includes undergraduate honors physics at Carleton University, followed by medical school, general surgery training, and a doctoral degree in basic science from McGill University, and thoracic surgery and critical care medicine training at the University of Ottawa.  He currently is both an ICU intensivist and thoracic surgeon at The Ottawa Hospital.  Scholarly interests include theoretical research exploring the clinical insights of complex systems science, experimental research applying continuous variability analysis at the bedside and development of means to continuously monitor quality of surgical care.

Andrew is the founder and Chief Science officer of Therapeutic Monitoring Systems, whose mission is to develop and evaluate software to perform continuous monitoring of multi-organ variability in order to improve care for patients at risk for or with existing critical illness.  Andrew has published over 35 peer-reviewed papers, presented at numerous international meetings, and was awarded a “New Investigator” Award by the Canadian Institutes of Health Research in 2005.

David Longbottom, Principal, Hot Towel Strategies

David is a customer-focused executive with over 25 years of technology management experience.  Now Principal at Hot Towel Strategies, Dave is helping a number of companies grow and develop as an investor and active advisor.  Currently this includes Therapeutic Monitoring Systems (board member), T-Base Communications (President & CEO) and Openera Ventures (advisor).  Previous board roles include GridIron Software (Chairman) & Zeligsoft (Chairman), among others.

Previously he was President and CEO of Chrysalis-ITS, where he successfully turned around the failing security appliance maker, attracting an acquisition by Rainbow/Safenet (NASDAQ:SFNT) in late 2003. Prior to joining Chrysalis, he helped SpeechFront, a speech recognition application company, raise financing and develop their go-to-market strategy resulting in an acquisition offer from Nuance (NASDAQ: NUAN) after only 6 months of operation.  Between 1995 and 2000 Dave helped to build and grow ObjecTime, a leader in advanced software development tools, serving first as Vice-President, Sales and Marketing, and ultimately COO.  ObjecTime completed a successful combination with market gorilla Rational Software (NASDAQ: RATL, now IBM) in early 2000. Prior to this, he held positions of increasing scope and responsibility at BNR/Nortel across a range of functions including software development, product management, marketing and sales.  Dave studied electrical engineering and holds a bachelors degree from Queen’s University and holds a U.S. technology patent for fault tolerant networking.